Tikehau Capital, Sprim join forces with new S'pore-based life sciences VC fund

Singapore

LIFE science startups hoping for a big break can now look to a new Singapore-based cash cow for funding.

European asset manager Tikehau Capital and Sprim Ventures, the venture arm of global healthcare consultancy Sprim, have teamed up to launch a venture capital (VC) fund for early-stage investments.